Target intelligence / Profile preview

Presynaptic neurotoxin

Molecular classification
Enzyme, Protein, Toxin, Other
01

Overview

Presynaptic neurotoxins are a functionally defined group of toxins—commonly found in animal venoms (notably snakes), Clostridium bacteria (e.g., botulinum, tetanus toxins), and some arthropods—that target the presynaptic terminals of neurons. They disrupt neurotransmitter release mechanisms, either by enzymatic cleavage of vesicle-associated proteins (e.g., SNARE proteins) or by damaging the presynaptic membrane (e.g., via phospholipase activity). The result is typically blockade of synaptic transmission at the neuromuscular junction, leading to neuroparalytic syndromes such as flaccid or spastic paralysis. Due to their high specificity and potency, some presynaptic neurotoxins have been studied for therapeutic use (e.g., botulinum toxin for spasticity) as well as for fundamental neuroscience research. The class is highly heterogeneous, with members varying in structure, mechanism, and clinical relevance[5][1][2][4].

Other names
β-neurotoxinpresynaptic toxinpre-junctional neurotoxin
02

Mechanism of action

Enzymatic cleavage of synaptic proteins (e.g., botulinum/tetanus toxins cleave SNARE proteins to prevent vesicle fusion); Phospholipid hydrolysis (specific snake PLA2 neurotoxins disrupt presynaptic membranes); Blockade or modulation of ion channels (some target Ca2+, K+, or other presynaptic ion channels)

03

Biological functions

Block neurotransmitter releaseNeuromuscular blockadeNeuromodulation or neuromuscular paralysis
04

Disease associations

Neurodegenerative diseaseMuscle paralysisOther
05

Safety considerations

Severe neurotoxicity (irreversible paralysis, respiratory failure)High potency, potential lethalityChallenges in antidote development (often limited to supportive care or specific antitoxins)
06

Interacting drugs

Antitoxins (e.g., botulinum antitoxin, tetanus immune globulin)

Beyond the preview

Go deeper on Presynaptic neurotoxin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Presynaptic neurotoxin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call